Postprandial Hypoglycemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-01-29
Clinical Trial Update: Canakinumab for the Treatment of Postprandial Hypoglycemia [Phase 3]
A Phase 3 clinical trial evaluating canakinumab for postprandial hypoglycemia is currently recruiting at University Hospital Basel.